Header cover image

Indonesian (IDX) Pharma Industry Analysis

UpdatedJan 20, 2022
DataAggregated Company Financials
Companies9
  • 7D-2.5%
  • 3M8.7%
  • 1Y-12.6%
  • YTD0.9%

Over the last 7 days, the Pharma industry has dropped 2.5%, driven by a decline by Kimia Farma (Persero) of 11%. However, the industry is down 13% over the past year.

Industry Valuation and Performance

Has the Indonesian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Fri, 21 Jan 2022Rp118.8tRp63.2tRp5.1t24.7x
Sun, 19 Dec 2021Rp118.0tRp63.1tRp5.1t24.7x
Tue, 16 Nov 2021Rp114.7tRp60.3tRp4.4t25x
Thu, 14 Oct 2021Rp106.4tRp58.5tRp4.3t21.1x
Sat, 11 Sep 2021Rp107.9tRp57.5tRp4.3t23.1x
Mon, 09 Aug 2021Rp98.1tRp57.5tRp4.3t20.4x
Sun, 02 May 2021Rp108.5tRp56.1tRp4.1t24.3x
Wed, 03 Feb 2021Rp113.0tRp55.7tRp4.0t22.1x
Sat, 07 Nov 2020Rp118.2tRp54.4tRp3.9t19.1x
Fri, 31 Jul 2020Rp105.1tRp48.8tRp3.7t15.7x
Mon, 04 May 2020Rp88.2tRp49.5tRp3.6t9.9x
Thu, 06 Feb 2020Rp85.5tRp48.3tRp3.5t11x
Sun, 10 Nov 2019Rp105.0tRp47.7tRp3.7t12.2x
Sat, 03 Aug 2019Rp106.3tRp47.1tRp3.7t14x
Tue, 07 May 2019Rp115.2tRp45.9tRp3.8t15.3x
Fri, 08 Feb 2019Rp119.9tRp44.8tRp3.8t14.6x
PE Ratio

14.6x

Total Market Cap: Rp119.9tTotal Earnings: Rp3.8tTotal Revenue: Rp44.8t0%0%0%3 Year10 Year
202020212022

Current Industry PE: Investors are more optimistic on the industry, considering it's trading at a PE ratio of 24.7x which is higher than its 3-year average PE of 17.1x. It appears they are confident that earnings will grow faster in the future than they have historically.

Past Earnings Growth: The earnings for companies in the Pharmaceuticals industry have grown 10% per year over the last three years, and revenues for these companies have grown 12% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Indonesian Pharma industry?

Pharma-2.53%

Industry PE: Investors are most optimistic about the Pharma industry which is trading above its 3-year average PE ratio of 17.1x. However analysts are expecting annual earnings growth of 2.7%, which is lower than the prior year's growth of 15% per year. So the market might believe that analysts are underestimating future growth.

Forecasted Growth: Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 2.7% over the next 5 years. However this is lower than its past earnings growth rate of 15% per year.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
TSPC Tempo Scan PacificRp1.49k0.3%
+Rp22.5b
-6.3%PE8x
MERK MerckRp3.85k0.3%
+Rp4.5b
15.3%PE12.8x
PEHA PhaprosRp1.12k0.4%
+Rp4.2b
-31.7%PE100.5x
Simply Wall St™
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News